EA200970420A1 - Применение mtki 1 для лечения или предупреждения рака кости - Google Patents
Применение mtki 1 для лечения или предупреждения рака костиInfo
- Publication number
- EA200970420A1 EA200970420A1 EA200970420A EA200970420A EA200970420A1 EA 200970420 A1 EA200970420 A1 EA 200970420A1 EA 200970420 A EA200970420 A EA 200970420A EA 200970420 A EA200970420 A EA 200970420A EA 200970420 A1 EA200970420 A1 EA 200970420A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- bone
- bone cancer
- prevention
- treatment
- cancer
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/529—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim forming part of bridged ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US86316706P | 2006-10-27 | 2006-10-27 | |
EP06123060 | 2006-10-27 | ||
US97618807P | 2007-09-28 | 2007-09-28 | |
PCT/EP2007/061501 WO2008049904A2 (en) | 2006-10-27 | 2007-10-25 | Use of mtki 1 for treating or preventing bone cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
EA200970420A1 true EA200970420A1 (ru) | 2009-12-30 |
Family
ID=39066650
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200970420A EA200970420A1 (ru) | 2006-10-27 | 2007-10-25 | Применение mtki 1 для лечения или предупреждения рака кости |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP2101782A2 (ja) |
JP (1) | JP2010507628A (ja) |
KR (1) | KR20090086977A (ja) |
AU (1) | AU2007310845A1 (ja) |
BR (1) | BRPI0718021A2 (ja) |
CA (1) | CA2664165A1 (ja) |
EA (1) | EA200970420A1 (ja) |
IL (1) | IL198344A0 (ja) |
MX (1) | MX2009004438A (ja) |
NO (1) | NO20092059L (ja) |
WO (1) | WO2008049904A2 (ja) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PA8603801A1 (es) * | 2003-05-27 | 2004-12-16 | Janssen Pharmaceutica Nv | Derivados de la quinazolina |
JO3088B1 (ar) * | 2004-12-08 | 2017-03-15 | Janssen Pharmaceutica Nv | مشتقات كوينازولين كبيرة الحلقات و استعمالها بصفتها موانع كينيز متعددة الاهداف |
GB0507347D0 (en) * | 2005-04-12 | 2005-05-18 | Astrazeneca Ab | Chemical compounds |
-
2007
- 2007-10-25 KR KR1020097009079A patent/KR20090086977A/ko not_active Application Discontinuation
- 2007-10-25 BR BRPI0718021-7A patent/BRPI0718021A2/pt not_active Application Discontinuation
- 2007-10-25 MX MX2009004438A patent/MX2009004438A/es unknown
- 2007-10-25 EP EP07821864A patent/EP2101782A2/en not_active Withdrawn
- 2007-10-25 AU AU2007310845A patent/AU2007310845A1/en not_active Abandoned
- 2007-10-25 EA EA200970420A patent/EA200970420A1/ru unknown
- 2007-10-25 JP JP2009533852A patent/JP2010507628A/ja not_active Withdrawn
- 2007-10-25 WO PCT/EP2007/061501 patent/WO2008049904A2/en active Application Filing
- 2007-10-25 CA CA002664165A patent/CA2664165A1/en not_active Abandoned
-
2009
- 2009-04-23 IL IL198344A patent/IL198344A0/en unknown
- 2009-05-27 NO NO20092059A patent/NO20092059L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
NO20092059L (no) | 2009-06-29 |
KR20090086977A (ko) | 2009-08-14 |
IL198344A0 (en) | 2010-02-17 |
MX2009004438A (es) | 2009-05-11 |
EP2101782A2 (en) | 2009-09-23 |
WO2008049904A3 (en) | 2009-01-15 |
AU2007310845A1 (en) | 2008-05-02 |
WO2008049904A2 (en) | 2008-05-02 |
JP2010507628A (ja) | 2010-03-11 |
BRPI0718021A2 (pt) | 2013-11-12 |
CA2664165A1 (en) | 2008-05-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20081935L (no) | HIV-integraseinhibitorer | |
WO2008079988A3 (en) | Quinazolines for pdk1 inhibition | |
EA200900613A1 (ru) | Спирокетоновые ингибиторы ацетил-коа-карбоксилаз | |
WO2008051416A3 (en) | Compounds that inhibit the activity of hsp90 for treating infections | |
WO2008060767A3 (en) | Macrocyclic benzofused pyrimidine derivatives | |
WO2008118823A3 (en) | Compositions and methods for inhibition of the jak pathway | |
WO2007117607A3 (en) | Quinazolines for pdk1 inhibition | |
MX2009006536A (es) | Compuestos de heteroaril-heteroarilo como inhibidores de cdk para el tratamiento de cancer, inflamacion e infecciones virales. | |
WO2007092622A3 (en) | Compositions and methods for treating bone | |
EA200900802A1 (ru) | Способы и композиции для лечения амилоидных заболеваний | |
WO2007098507A3 (en) | Compositions and methods for inhibition of the jak pathway | |
TW200700422A (en) | Compounds for inhibiting ksp kinesin activity | |
EA201100874A1 (ru) | Соединения для лечения рака | |
DK2054418T3 (da) | Dihydrothieno-pyrimidiner som AKT-proteinkinase-inhibitorer | |
WO2012068096A3 (en) | Benzoxazepines as inhibitors of pi3k/mtor and methods of their use and manufacture | |
WO2012068106A3 (en) | Benzoxazepines as inhibitors of pi3k/mtor and methods of their use and manufacture | |
WO2007016338A3 (en) | Use of chk2 kinase inhibitors for cancer treatment | |
EA201000895A1 (ru) | Композиции и способы для лечения лизосомных болезней | |
WO2008133734A3 (en) | Method and compositions for treating hiv infections | |
MX2008015775A (es) | Compuestos y composiciones para tratamiento de cancer. | |
MX2009002960A (es) | Inhibidores de serina hidrolasa. | |
WO2007112121A3 (en) | Tetracycline compounds and methods of treatment | |
TW200801018A (en) | 6,6-bicyclic ring substituted sulfur containing heterobicyclic protein kinase inhibitors | |
EA200800570A1 (ru) | Фосфонированные рифамицины и их применение для профилактики и лечения костных и суставных инфекций | |
EA201170344A1 (ru) | Азаиндольные ингибиторы iap |